A Non Interventional Study With Irinotecan Onkovis (Irinotecan) Utilized for the Treatment of Cancer

The main purpose of this observational study with Irinotecan onkovis is to determine the number of treatment cycles and the quantity of Irinotecan onkovis needed for this purpose under the special circumstances of ambulant chemotherapy.
Onkovis aims to contribute to an economical utilization of the chemotherapeutics. This includes provision of appropriate packaging sizes to decrease the excess quantity to be discarded, and thus also follows this objective.
Secondary objective is the assessment of the side effects of Irinotecan onkovis. To this end, data regarding co-medication and adverse events are also collected.

本项针对伊立替康Onkovis（Irinotecan onkovis）的观察性研究的主要目的为，明确门诊化疗特殊场景下，完成该治疗所需的治疗周期数与伊立替康Onkovis的总使用量。
Onkovis的研发目标在于实现化疗药物的经济化合理应用，具体举措包括提供适配的包装规格以减少需废弃的剩余药量，本研究亦以此为目标导向。
本研究的次要目的为评估伊立替康Onkovis的不良反应，为此同步收集合并用药与不良事件相关数据。